Conversion therapy of a giant hepatocellular carcinoma with portal vein thrombus and inferior vena cava thrombus: A case report and review of literature

作者
Wenjie Song,Jian Xu,Ye Nie,Weimin Li,Jianping Li,Li Yang,Mengqi Wei,Kaishan Tao
出处
期刊:World Journal of Clinical Cases [Baishideng Publishing Group]
卷期号:12 (16): 2847-2855 被引量:7
标识
DOI:10.12998/wjcc.v12.i16.2847
摘要

Abstract Background The prognosis of HCC combined with portal and hepatic vein tumor thrombus is poor, with a median survival time of only about 2.7-3 months [1], and treatment requires the cooperation of the MDT team. Prof. Cheng's team gives treatment recommendations based on the classification of portal vein thrombosis and hepatic vein thrombosis. For portal vein tumor thrombus involving the main trunk of the portal vein (PVTT III) and hepatic vein tumor thrombus involving the inferior vena cava, a combination of radiotherapy, TACE, and surgical resection is recommended according to the patient's liver function [2, 3]. The combination of targeted therapy and immune therapy has progressed to become the first-line recommended treatment for advanced HCC [4]. Conversion therapy or conversion surgery (CS) is a surgical strategy developed to improve long-term survival in patients with initially unresectable tumors, aiming at R0 resection after stage reduction by non-surgical treatment [5].CS has also been reported in HCC, radical resection of partially unresectable HCC (UR-HCC) has been achieved through transcatheter arterial chemoembolization (TACE), portal vein embolization, and oral administration of molecular targeted drugs [6.7]. In recent years, the efficacy of atilizumab combined with bevacizumab (Atez + Bev) in the treatment of UR-HCC has been confirmed [8–10]. The above therapeutic advances have brought hope for advanced HCC, but the efficacy is still limited. In our center, a patient with giant HCC combined with portal vein tumor thrombus and hepatic vein tumor thrombus was treated with TACE, radiotherapy, targeted therapy and immunotherapy, and was continuously given Epimedium soft capsules for oral regulation. After 7 months of conversion therapy, the patient's tumor shrank and the tumor thrombus subsided significantly. The pathology of surgical resection was in complete remission, and there was no progression in the postoperative follow-up for 7 months, which provided a basis for the future strategy of combined conversion therapy.CONCLUSION In this case, atezolizumab, bevacizumab, icaritin soft capsules combined with radiotherapy and TACE had a good effect. For patients with hepatocellular carcinoma combined with hepatic vein/inferior vena cava tumor thrombus, adopting a high-intensity, multimodal proactive strategy under the guidance of MDT is an important attempt to break through the current treatment dilemma.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
李健的小迷弟的应助被Dillen采纳,获得10
2秒前
优美不惜完成签到,获得积分10
2秒前
2秒前
欢喜冰海发布了新的文献求助10
3秒前
冷酷海安发布了新的文献求助10
3秒前
wangSF完成签到,获得积分10
3秒前
土豆你个西红柿完成签到,获得积分10
3秒前
下雨了完成签到,获得积分10
4秒前
CZ88完成签到 ,获得积分10
4秒前
4秒前
zhangjy226发布了新的文献求助10
4秒前
4秒前
yun完成签到,获得积分10
4秒前
5秒前
5秒前
5秒前
菠菜发布了新的文献求助30
5秒前
6秒前
花开富贵完成签到,获得积分10
6秒前
哪位完成签到,获得积分10
6秒前
吕多多多发布了新的文献求助10
6秒前
科研助手完成签到 ,获得积分10
6秒前
Jasper的应助被西蓝花采纳,获得10
7秒前
高CA发布了新的文献求助10
7秒前
7秒前
8秒前
蔡俞隆完成签到 ,获得积分10
8秒前
地瓜发布了新的文献求助10
10秒前
星辰大海的应助被lmy采纳,获得10
10秒前
1215发布了新的文献求助30
10秒前
11秒前
cy完成签到,获得积分10
11秒前
11秒前
ZLRH0618发布了新的文献求助10
11秒前
fantasy的应助被baibai采纳,获得10
12秒前
学术雷锋发布了新的文献求助10
12秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161320
求助须知:如何正确求助?哪些是违规求助? 9556074
关于积分的说明 21732157
捐赠科研通 7751456
什么是DOI,文献DOI怎么找? 3427537
关于科研通互助平台的介绍 2552583
邀请新用户注册赠送积分活动 2471992